Allowing states to import cheaper prescription drugs from Canada as a method of lowering drug costs for residents of the United States makes no sense to former FDA Commissioner Robert Califf, who says the country ought to buckle down instead on using purchasing power to negotiate domestic drug prices and force drug companies to negotiate more effectively with other wealthy countries to ensure they pay prices that aren’t significantly less than what the United States faces.
- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us